How many 8-K filings has Standard Biotools Inc. filed?

Standard Biotools Inc. (LAB) has 24 8-K (Current Event Report) filings on record, spanning Jan 2024 to Sep 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Standard Biotools Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Standard Biotools Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Standard Biotools Inc. (LAB) — 8-K Filings

All 8-K filings from Standard Biotools Inc.. Browse 24 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (24)

Standard BioTools Reports Exit/Disposal Costs — Sep 17, 2025 Risk: medium
Standard BioTools Inc. filed an 8-K on September 17, 2025, reporting on cost associated with exit or disposal activities as of September 13, 2025. The filing do
Standard BioTools Reports Exit/Disposal Costs — Sep 3, 2025 Risk: medium
Standard BioTools Inc. filed an 8-K on August 28, 2025, reporting costs associated with exit or disposal activities. The filing does not specify the exact natur
Standard BioTools Inc. Files 8-K on Financials — Aug 11, 2025 Risk: low
Standard BioTools Inc. filed an 8-K on August 11, 2025, reporting on its results of operations and financial condition. The filing also includes information rel
Standard BioTools Elects New Directors — Aug 1, 2025 Risk: low
Standard BioTools Inc. announced on July 29, 2025, a change in its board of directors. Specifically, the company elected two new directors, Dr. Jonathan M. Roth
Standard BioTools Inc. Files 8-K for Material Agreement — Jun 23, 2025 Risk: medium
On June 22, 2025, Standard BioTools Inc. entered into a material definitive agreement. The filing also includes Regulation FD disclosures and financial statemen
Standard BioTools Announces Director/Officer Changes & Shareholder Vote — Jun 20, 2025 Risk: medium
Standard BioTools Inc. announced on June 18, 2025, a series of significant corporate actions. These include the departure of certain directors and officers, the
Standard BioTools Files 8-K on Financials — Feb 26, 2025 Risk: low
Standard BioTools Inc. filed an 8-K on February 26, 2025, reporting on its Results of Operations and Financial Condition, Regulation FD Disclosure, and Financia
Standard BioTools Files 8-K on Financials — Jan 13, 2025 Risk: low
Standard BioTools Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD
Standard BioTools Relocates HQ, Hints at Officer Changes — Jan 10, 2025 Risk: low
Standard BioTools Inc. announced on January 3, 2025, a change in its principal executive offices to 2 Tower Place, Suite 2000, South San Francisco, California 9
Standard BioTools Files 8-K for Financials and Exhibits — Dec 20, 2024 Risk: low
Standard BioTools Inc. filed an 8-K on December 20, 2024, reporting events as of December 19, 2024. The filing primarily concerns financial statements and exhib
Standard BioTools Elects New Directors, Updates Exec Pay — Nov 7, 2024 Risk: medium
Standard BioTools Inc. announced on November 6, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new di
Standard BioTools Files 8-K on Financials — Oct 30, 2024 Risk: medium
Standard BioTools Inc. filed an 8-K on October 30, 2024, reporting on its results of operations and financial condition. The filing also includes Regulation FD
Standard BioTools Files 8-K: Regulation FD & Exhibits — Sep 5, 2024 Risk: low
On September 5, 2024, Standard BioTools Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits.
Standard BioTools Elects New Directors, Board Changes — Aug 30, 2024 Risk: medium
Standard BioTools Inc. announced on August 27, 2024, the election of two new directors, Dr. Jonathan M. Rothberg and Mr. David E. R. King, to its Board of Direc
Standard BioTools Elects New Directors — Jul 31, 2024 Risk: medium
Standard BioTools Inc. announced on July 26, 2024, a change in its board of directors. Specifically, the company elected two new directors, Dr. Jonathan M. Roth
Standard BioTools Files 8-K on Financials — Jul 31, 2024 Risk: low
Standard BioTools Inc. filed an 8-K on July 31, 2024, to report on its results of operations and financial condition. The filing also includes information relat
Standard BioTools Adds Two Directors to Board — Jul 1, 2024 Risk: low
Standard BioTools Inc. announced on June 27, 2024, the election of two new directors, Dr. Jonathan M. Rothberg and Mr. David E. R. Harding, to its Board of Dire
Standard BioTools Sells Fluidigm to Revvity for $335M — Jun 3, 2024 Risk: medium
Standard BioTools Inc. announced on May 31, 2024, that it has entered into a definitive agreement to sell its Fluidigm business to Revvity, Inc. for $335 millio
Standard BioTools Completes Asset Acquisition — May 8, 2024 Risk: low
Standard BioTools Inc. announced on May 8, 2024, the completion of its acquisition of assets from a third party. The company, formerly known as Fluidigm Corp, i
Standard BioTools Inc. Files 8-K on Exit Costs — Apr 25, 2024 Risk: medium
Standard BioTools Inc. filed an 8-K on April 25, 2024, reporting on events as of April 19, 2024. The filing indicates costs associated with exit or disposal act
Standard BioTools Inc. Files 8-K with Key Corporate Updates — Mar 18, 2024 Risk: medium
Standard BioTools Inc. announced on March 18, 2024, several key events including entering into a material definitive agreement, unregistered sales of equity sec
Standard BioTools Files 8-K on Operations and Financial Condition — Feb 28, 2024 Risk: low
Standard BioTools Inc. filed an 8-K on February 28, 2024, reporting on Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial St
Standard BioTools Files 8-K on Operations & Financial Condition — Jan 8, 2024
Standard BioTools Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition, along with Regulation FD Disclosure and
Standard BioTools 8-K Signals Potential M&A Activity — Jan 5, 2024
Standard BioTools Inc. filed an 8-K on January 5, 2024, reporting an event that occurred on January 4, 2024. This filing indicates the company is simultaneously

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX